Financial giants have made a conspicuous bullish move on Advanced Micro Devices. Our analysis of options history for Advanced Micro Devices (NASDAQ:AMD) revealed 29 unusual trades. Delving into the ...

Biliary tract cancers, including intrahepatic, perihilar, and extrahepatic cholangiocarcinoma and gallbladder cancer, are among the most aggressive gastrointestinal malignancies. Treatment options ...

A quiet epidemic haunts the glowing screens of this globally connected world: digital loneliness. People possess thousands of friends across social platforms yet feel profoundly isolated. The very ...

A freshly installed system starts up quickly and responds swiftly. A few updates and new software installations later, however, Windows seems to become slower and slower. There are several ways to ...

When Navneet Gupta left his employer in 2020, he walked out with more than experience—a life-changing Esop payout. As an early employee, his stock options grew in tandem with the company’s rapid rise, ...

Dec 1 (Reuters) - U.S. chipmaker Marvell Technology (MRVL.O), opens new tab is in advanced talks to acquire chip startup Celestial AI in a cash-and-stock deal worth multiple billions of dollars, the ...

PALO ALTO, Calif.—On a quiet residential street a few blocks from Stanford University, two former Google researchers are launching a startup they hope will remake the $800 billion chip industry. Anna ...

Yann LeCun, the artificial intelligence pioneer who is leaving Meta Platforms Inc. at the end of the year, said Meta will not financially back his new AI company and hinted it could be based in Paris.

Options and futures are sophisticated financial instruments that provide investors with unique opportunities to enhance their portfolios. These tools are not for the faint-hearted, as they require a ...

Imfinzi (durvalumab) is an immunotherapy medicine that helps the immune system detect and attack cancer cells. The FDA has approved a combination of Imfinzi and standard chemotherapy medicines – ...

WASHINGTON, Dec 8 (Reuters) - A fledgling social media platform has asked the U.S. Patent and Trademark Office to cancel trademarks for Twitter so it can take them for itself, contending that ...